TXT
묘사:
Diatrizoate Meglumine Injection
MRC:
The ingredients compounded in a pharmaceutical preparation and recognized as having therapeutic value/s/. /usually representative in the item name generic nomenclature./AKJA
Active Medicament Medicinal Strength:
60.000 percentage, w/v meglumine diatrizoate active ingredient
MRC:
The liquid nontoxic component form of a pharmacuetical preparation which normally has no therapeutic action,and presents the active ingredients to the body for absorption.AKJQ
Pharmaceutical Vehicle Type:
Aqueous
MRC:
Those features,not otherwise specified,which may be required for proper functioning of the item.CBBL
Features Provided:
Sterile
MRC:
Indicates the type of container/s/ or supporting device/s/ which is in direct contact with the item.CQCT
Primary Container Type:
Vial
MRC:
A numeric value of the volume,form,or dosage within each primary container.CRLK
Primary Container Content Quantity:
100.000 milliliters
MRC:
The number of primary containers within the item of supply.CSCW
Total Primary Container Quantity:
20
MRC:
An indication of the area,orifice,or tissue of the body to which the medication is administered or applied,based on the drug formulation.CSGS
Administration:
Intravenous
MRC:
Indicates the type of container in which the item of supply is packaged.PKTY
Unit Package Type:
Box
MRC:
An indication of the same predictable therapeutic effect as determined by the food and drug administration (fda) for an item of supply when administered under the conditions as specified in the labeling.THPE
Therapeutic Equivalent:
Rated ap
